Biomarker identification and validation

Biomarker identification and validation

splash 14PsyRING's experience with biomarkers can bridge the preclinical-clinical gap and allow the rapid assessment of clinical efficacy.

World-leading expertise, combined with access to state-of-the-art genomic, proteomic and bioinformatic facilities, provides a unique integrated service, to identify and validate potential biomarkers.

  • Access to clinical tissue
  • State-of-the-art facility
  • Expertise in analysis

Potential biomarkers can be assessed in relevant clinical populations through Psyring's excellent collaborative links with the NHS.